Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
HBIO
IXHL
Add up to 3 more stocks
HBIO
Harvard Bioscience, Inc.
+0.71%
$8.56+0.06Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$38.61M
52W Range
$3.76 - $9.40
IXHL
Incannex Healthcare Limited
-1.25%
$3.17-0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$37.93M
52W Range
$2.40 - $49.80
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.20 | 0.56 |
| P/S Ratio | 0.44 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 10.54 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 58.2% | 0.0% |
| Operating Margin | 1.2% | 0.0% |
| Net Margin | -11.9% | 0.0% |
| ROE | -140.4% | -28.6% |
| ROA | -13.7% | -26.4% |
| ROIC | 2.0% | -32.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.87 | 48.81 |
| Quick Ratio | 0.98 | 48.81 |
| Debt/Equity | 5.96 | 0.00 |
| Interest Coverage | -0.13 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.